Invasive cerebral aspergillosis in non-neutropenic patients: A case series from Western India.
暂无分享,去创建一个
M. Garg | G. Bohra | Deepak Kumar | D. Meena | V. Jain | N. Midha | R. Akshatha | Subhashree Samantaray | S. Tiwari | T. Balamurugan
[1] G. Stroffolini,et al. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements , 2021, Annals of Intensive Care.
[2] G. Bohra,et al. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases. , 2021, Infectious diseases now.
[3] K. Marr,et al. Defining Galactomannan Positivity in the Updated EORTC/MSGERC Consensus Definitions of Invasive Fungal Diseases. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] J. Berger,et al. CNS fungal infections: A review , 2021, Journal of the Neurological Sciences.
[5] Shengyuan Yu,et al. Central nervous system aspergillosis in immunocompetent patients , 2020, Medicine.
[6] J. Perfect,et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] M. Miceli. Central Nervous System Infections Due to Aspergillus and Other Hyaline Molds , 2019, Journal of fungi.
[8] O. Lortholary,et al. Why are so many cases of invasive aspergillosis missed? , 2019, Medical mycology.
[9] M. Khanna,et al. CNS aspergilloma mimicking tumors: Review of CNS aspergillus infection imaging characteristics in the immunocompetent population. , 2017, Journal of neuroradiology. Journal de neuroradiologie.
[10] D. Denning,et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] J. Dietemann,et al. Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations , 2016, PloS one.
[12] G. Driessen,et al. Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid , 2015, Journal of Clinical Microbiology.
[13] S. Tsuji,et al. Recurrent cerebral aneurysm formation and rupture within a short period due to invasive aspergillosis of the nasal sinus; pathological analysis of the catastrophic clinical course. , 2015, International journal of clinical and experimental pathology.
[14] Venkatraman Bhat,et al. Invasive aspergillosis presenting as swelling of the buccal mucosa in an immunocompetent individual. , 2015, Oral surgery, oral medicine, oral pathology and oral radiology.
[15] T. Madani,et al. Isolated cerebral aspergillosis in immunocompetent patients. , 2014, World neurosurgery.
[16] J. Rello,et al. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. , 2014, International journal of antimicrobial agents.
[17] M. Hoenigl,et al. Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis. , 2013, Current pharmaceutical design.
[18] S. Antinori,et al. Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases , 2012, Journal of Infection.
[19] E. Mylonakis,et al. Central Nervous System Aspergillosis: A Series of 14 Cases From a General Hospital and Review of 123 Cases From the Literature , 2012, Medicine.
[20] J. Baddley. Clinical risk factors for invasive aspergillosis. , 2011, Medical mycology.
[21] I. Velasco,et al. Cerebral vasculitis caused by Aspergillus simulating ischemic stroke in an immunocompetent patient. , 2010, The Journal of emergency medicine.
[22] Patricia Muñoz,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] R. Jooma,et al. Craniocerebral aspergillosis in immunocompetent hosts: surgical perspective. , 2007, Neurology India.
[24] A. Chakrabarti. Epidemiology of central nervous system mycoses. , 2007, Neurology India.
[25] C. Viscoli,et al. Aspergillus Galactomannan Antigen in the Cerebrospinal Fluid of Bone Marrow Transplant Recipients with Probable Cerebral Aspergillosis , 2002, Journal of Clinical Microbiology.